AMGN - AMGEN INC
IEX Last Trade
263.425
-69.485 -26.378%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:57:26 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.46%
PREVIOUS CLOSE
CHG
CHG%
$332.91
5.58
0.02%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-04 | 2023-02-09 | 2023-04-28 | 2023-08-04 | 2023-10-31 | 2024-02-14 | 2024-05-03 | |
| Assets | |||||||||
| Total Assets | 59.294 B | 63.700 B | 65.121 B | 88.720 B | 90.269 B | 90.534 B | 97.154 B | 92.980 B | |
| Current Assets | 19.322 B | 24.062 B | 22.186 B | 44.703 B | 47.380 B | 48.477 B | 30.332 B | 28.029 B | |
| Inventories | 4.554 B | 4.757 B | 4.930 B | 5.011 B | 4.978 B | 5.026 B | 9.518 B | 8.724 B | |
| Other Current Assets | 2.258 B | 2.501 B | 2.259 B | 2.395 B | 2.324 B | 2.565 B | 2.430 B | 2.821 B | |
| Short Term Investments | 2.258 B | 2.501 B | 2.259 B | 2.395 B | 2.324 B | 2.565 B | 2.430 B | 2.821 B | |
| Total Receivables | 5.327 B | 5.326 B | 5.692 B | 5.736 B | 5.830 B | 6.145 B | 7.440 B | 6.776 B | |
| Current Cash | 7.183 B | 11.478 B | 9.305 B | 31.561 B | 34.248 B | 34.741 B | 10.944 B | 9.708 B | |
| Total Non-current Assets | 39.972 B | 39.638 B | 42.935 B | 44.017 B | 42.889 B | 42.057 B | 66.822 B | 64.951 B | |
| Property Plant Equipment | 5.158 B | 5.188 B | 5.427 B | 5.460 B | 5.532 B | 5.563 B | 5.941 B | 6.002 B | |
| Other Assets | 6.022 B | 6.339 B | 5.899 B | 7.633 B | 7.193 B | 7.835 B | 9.611 B | 9.007 B | |
| Intangible Assets | 13.927 B | 13.266 B | 16.080 B | 15.393 B | 14.633 B | 13.150 B | 32.641 B | 31.372 B | |
| Goodwill | 14.865 B | 14.845 B | 15.529 B | 15.531 B | 15.531 B | 15.509 B | 18.629 B | 18.570 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 59.294 B | 63.700 B | 65.121 B | 88.720 B | 90.269 B | 90.534 B | 97.154 B | 92.980 B | |
| Total liabilities | 56.875 B | 60.047 B | 61.460 B | 83.372 B | 83.488 B | 82.878 B | 90.922 B | 87.958 B | |
| Total current liabilities | 12.618 B | 14.331 B | 15.687 B | 14.215 B | 17.097 B | 16.954 B | 18.392 B | 19.714 B | |
| Accounts Payable | 1.256 B | 1.204 B | 1.572 B | 1.320 B | 1.212 B | 1.358 B | 1.590 B | 1.628 B | |
| Other liabilities | 8.552 B | 8.555 B | 8.419 B | 8.396 B | 7.014 B | 6.884 B | 7.006 B | 6.321 B | |
| Current long term debt | 817.000 M | 1.543 B | 1.591 B | 834.000 M | 2.167 B | 1.428 B | 1.443 B | 3.959 B | |
| Long term debt | 35.705 B | 37.161 B | 37.354 B | 60.761 B | 59.377 B | 59.040 B | 63.170 B | 60.061 B | |
| Other liabilities | 8.552 B | 8.555 B | 8.419 B | 8.396 B | 7.014 B | 6.884 B | 7.006 B | 6.321 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.419 B | 3.653 B | 3.661 B | 5.348 B | 6.781 B | 7.656 B | 6.232 B | 5.022 B | |
| Common stock | 535.000 M | 535.000 M | 534.000 M | 534.000 M | 535.000 M | 535.000 M | 536.000 M | 536.000 M | |
| Retained earnings | -28.252 B | -28.066 B | -28.622 B | -26.919 B | -25.540 B | -24.971 B | -26.549 B | -27.870 B |